Our company is committed to the development of next-generation therapeutics to overcome untreatable cancers and enable futures for our patients.
Live Beyond Cancer
43,700 patients with metastatic breast cancer will die within the next 12 months.
13,270 patients with metastatic ovarian cancer will die within the next 12 months.
50,550 patients with metastatic pancreatic cancer will die within the next 12 months.
18,990 patients with glioblastoma will die within the next 12 months.
609,820 patients will die within the next 12 months from their cancers.
Cancer Has Disrupted So Many Lives.
Now It’s Our Turn To Disrupt Cancer.
At etiraRx, we are dedicated to Outsmarting, Outfighting, And Outlasting Cancer.
See our science in the Nature Cancer publication from the lab of etiraRx founders, Drs. Ganesh Raj, Ratna Vadlamudi, Jung-Mo Ahn
See our pipeline for solid tumors
Join us here for updates